Orencia

Active Ingredient(s): Abatacept
FDA Approved: * December 23, 2005
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Arthritis

Abatacept, sold under the brand name Orencia, is a medication used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells.[1][3] It is a modified antibody.[1][3] Abatacept is a fusion protein composed of the Fc region of the immunoglobulin IgG1 fused to the extracellular domain of CTLA-4. In order for a T cell to be activated and produce an immune response, an antigen-presenting... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Orencia 250 mg/15ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0003-2187
Labeler:
E.r. Squibb & Sons, L.L.C.
Orencia 125 mg/ml Subcutaneous Injection, Solution
NDC: 0003-2188
Labeler:
E.r. Squibb & Sons, L.L.C.
Orencia 50 mg/.4ml Subcutaneous Injection, Solution
NDC: 0003-2814
Labeler:
E.r. Squibb & Sons, L.L.C.
Orencia 87.5 mg/.7ml Subcutaneous Injection, Solution
NDC: 0003-2818
Labeler:
E.r. Squibb & Sons, L.L.C.

Popular Topics

orencia

orencia possibly causing chest pain,shortness or breath? ## It sounds like you may be having an allergic reaction to thi...

2 REPLIES